- Bank of America reduced its stake in Abivax below the 5% threshold on Aug. 24, 2026.
- The holding fell to 4,182,454 shares, representing 4.79% of the capital, with voting rights declining to 4.73%.
- This adjustment followed market sales that were partially offset by positions held via swaps and other equity-linked contracts.
- The 2026 corporate financial reports and capital dynamics show diverging fundamentals across different sectors.
- Industrial and resource sectors like Constellium and Ferroglobe demonstrate strong cash flow resilience and are raising guidance or executing share buybacks.
- Meanwhile, micro and early-stage companies such as Apollomics and CN Energy face liquidity tests, compliance pressures, and funding management challenges.
- Benzinga's options scanner identified notable whale trading activity across 10 health care stocks during the session.
- The tracked transactions feature a mix of bullish and bearish call option trades and sweeps with varying expiration dates and strike prices.
- Notable activity includes ELV with a bullish trade totaling $564.0K and LQDA with a bullish sweep totaling $138.0K.